Tags

Type your tag names separated by a space and hit enter

Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
Respirology 2008; 13(5):689-94R

Abstract

BACKGROUND AND OBJECTIVE

The prevalence of COPD in the Western Pacific is increasing. The present study determined the total direct health-care costs for the management of COPD patients with differing degrees of disease severity. The study also aimed to find the key cost drivers in the management of COPD.

METHODS

COPD patients were recruited from a tertiary care hospital during April 2002 and March 2003. One-year costs were identified by applying cost data to medical information obtained by review of medical records. Costs included those for medications, oxygen therapy, laboratory and diagnostic tests, clinic visits, emergency room visits and hospital stays.

RESULTS

There were 160 patients recruited. Patients were categorized by COPD severity: moderate A COPD (50 <or= FEV(1)% < 80; n = 54), moderate B COPD (30 <or= FEV(1)% < 50; n = 54) and severe COPD (FEV(1)% < 30; n = 52). Patients with moderate A, moderate B and severe COPD had an average of 0.82, 2.6 and 3.5 exacerbations per year, respectively. Average numbers of emergency room visits were 0.41 +/- 0.94, 1.20 +/- 1.39 and 1.73 +/- 2.44 per year in moderate A, moderate B and severe COPD patients, respectively. The mean total direct costs were New Taiwan dollars 288 825, 149 031 and 38 203 for severe COPD, moderate B COPD and moderate A COPD, respectively. The total annual cost was correlated with the disease severity. Hospitalization contributed the major portion of cost and also correlated with disease severity.

CONCLUSIONS

There is a correlation between the cost of COPD and disease severity with hospitalization owing to disease exacerbation being a major contributor to cost. The keys to reducing health-care costs lie with reducing the frequency of exacerbations and the disease severity.

Authors+Show Affiliations

Chest Department, Division of Pulmonary Immunology and Infectious Diseases, Taipei Veterans General Hospital, Taipei, Taiwan. chiang01@vghtpe.gov.tw

Pub Type(s)

Journal Article

Language

eng

PubMed ID

18513247

Citation

Chiang, Chi-Huei. "Cost Analysis of Chronic Obstructive Pulmonary Disease in a Tertiary Care Setting in Taiwan." Respirology (Carlton, Vic.), vol. 13, no. 5, 2008, pp. 689-94.
Chiang CH. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan. Respirology. 2008;13(5):689-94.
Chiang, C. H. (2008). Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan. Respirology (Carlton, Vic.), 13(5), pp. 689-94. doi:10.1111/j.1440-1843.2008.01308.x.
Chiang CH. Cost Analysis of Chronic Obstructive Pulmonary Disease in a Tertiary Care Setting in Taiwan. Respirology. 2008;13(5):689-94. PubMed PMID: 18513247.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan. A1 - Chiang,Chi-Huei, Y1 - 2008/05/29/ PY - 2008/6/3/pubmed PY - 2008/12/17/medline PY - 2008/6/3/entrez SP - 689 EP - 94 JF - Respirology (Carlton, Vic.) JO - Respirology VL - 13 IS - 5 N2 - BACKGROUND AND OBJECTIVE: The prevalence of COPD in the Western Pacific is increasing. The present study determined the total direct health-care costs for the management of COPD patients with differing degrees of disease severity. The study also aimed to find the key cost drivers in the management of COPD. METHODS: COPD patients were recruited from a tertiary care hospital during April 2002 and March 2003. One-year costs were identified by applying cost data to medical information obtained by review of medical records. Costs included those for medications, oxygen therapy, laboratory and diagnostic tests, clinic visits, emergency room visits and hospital stays. RESULTS: There were 160 patients recruited. Patients were categorized by COPD severity: moderate A COPD (50 <or= FEV(1)% < 80; n = 54), moderate B COPD (30 <or= FEV(1)% < 50; n = 54) and severe COPD (FEV(1)% < 30; n = 52). Patients with moderate A, moderate B and severe COPD had an average of 0.82, 2.6 and 3.5 exacerbations per year, respectively. Average numbers of emergency room visits were 0.41 +/- 0.94, 1.20 +/- 1.39 and 1.73 +/- 2.44 per year in moderate A, moderate B and severe COPD patients, respectively. The mean total direct costs were New Taiwan dollars 288 825, 149 031 and 38 203 for severe COPD, moderate B COPD and moderate A COPD, respectively. The total annual cost was correlated with the disease severity. Hospitalization contributed the major portion of cost and also correlated with disease severity. CONCLUSIONS: There is a correlation between the cost of COPD and disease severity with hospitalization owing to disease exacerbation being a major contributor to cost. The keys to reducing health-care costs lie with reducing the frequency of exacerbations and the disease severity. SN - 1440-1843 UR - https://www.unboundmedicine.com/medline/citation/18513247/Cost_analysis_of_chronic_obstructive_pulmonary_disease_in_a_tertiary_care_setting_in_Taiwan_ L2 - https://doi.org/10.1111/j.1440-1843.2008.01308.x DB - PRIME DP - Unbound Medicine ER -